medical oncology newsroom
Eduardo Davila, PhD, Receives Funding from NCI
Dr. Davila received R01 grant funding from the NCI to better understand why some melanoma patients don’t respond to immunotherapy, and to determine how to increase responsiveness in patients, eventually resulting in a Phase I clinical trial in patients with rare melanoma.
Jamie Studts, PhD, Bristol Myers Squibb Foundation Grant Recipient
Jamie Studts, PhD, has co-created a project designed to boost lung cancer screening rates in Kentucky earning a grant from the Bristol Myers Squibb Foundation.
Dr. Graham Discusses High-Dose Testosterone to Treat Prostate Cancer
Dr. Laura Graham, is currently leading a phase 2 trial studying whether high doses of testosterone are a feasible treatment against castration-resistant prostate cancer (CRPC) leading to a reduction in prostate cancer growth as well as improved quality of life.
Dr. Davila Discusses Importance of PIKE-PREP Program
PIKE-PREP offers students from URM communities multi-dimensional mentorship and research training designed to prepare them for enrollment and success in a top-tier PhD or MD/PhD program.
Deputy AD for Diversity and Inclusion in Clinical Research
Jessica McDermott, MD, Assistant Professor with the Division of Medical Oncology, has been named Deputy Associate Director for Diversity and Inclusion in Clinical Research. This role was recently created to identify and address barriers clinical trial accrual.
New Clinical Trial to Treat Metastatic Colorectal Cancer
Robert Lentz, MD, spearheads a new phase 2 clinical trial for patients with metastatic colon cancer for whom chemotherapy and biologic therapy are no longer effective options.
Improving Access to Genetic Counseling and Testing
Co-director of the hereditary cancer program, Marie Wood, MD, aims to increase patient awareness surrounding the importance of genetic counseling and genetic testing relating to cancer.
Recent Study Reduces Risk in Extracting Tumor Information
Dr. Kabos discusses his recent study analyzing blood plasma to extract critical breast tumor information and disease progression instead of more invasive tissue biopsies.